DJO Surgical: Empowr Knee, Universal Tibia Baseplate, 6R, REF: 352-02-106

FDA Device Recall #Z-2603-2023 — Class II — August 4, 2023

Recall Summary

Recall Number Z-2603-2023
Classification Class II — Moderate risk
Date Initiated August 4, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Encore Medical, LP
Location Austin, TX
Product Type Devices
Quantity 20

Product Description

DJO Surgical: Empowr Knee, Universal Tibia Baseplate, 6R, REF: 352-02-106

Reason for Recall

Orthopedic device components were not subjected to final sterilization before shipment, which if implanted may lead to varying degrees of infection, which may require treatment, prolonged monitoring, and may lead to revision surgery

Distribution Pattern

US: AL, AZ, CA, CO, FL, IL, IN, KS, KY, LA, MA, MI, MN, MO, NC, NJ, NY, OH, PA, PR, RI, SC, TX, UT, VA, WA. OUS: Sweden, Australia, France, UK, Colombia, Germany

Lot / Code Information

UDI-DI/Lot/Expiration: 00190446258032/308V1112/May 25, 2029

Other Recalls from Encore Medical, LP

Recall # Classification Product Date
Z-1460-2026 Class II Brand Name: Reverse Shoulder Prosthesis (RSP) ... Jan 15, 2026
Z-1458-2026 Class II Brand Name: Reverse Shoulder Prosthesis (RSP) ... Jan 15, 2026
Z-1459-2026 Class II Brand Name: EMPOWR 3D KNEE Product Name: EMPOW... Jan 15, 2026
Z-1234-2026 Class II EMPOWR Acetabular System: Liner, 10 degree Hood... Jan 5, 2026
Z-1233-2026 Class II EMPOWR 3D Knee Tibial Insert 5R 14MM, VE, REF: ... Jan 5, 2026

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.